Europe Approves Nivolumab for Head and Neck Cancer Europe Approves Nivolumab for Head and Neck Cancer

It ' s the first drug approved in this setting in Europe in more than a decade.International Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news